title: [Hypertension in pregnancy and future maternal health].
abstract: Preeclampsia is a specific risk factor chronic of hypertension, of coronary events (Ray et al., 2005), of stroke (Brown et al., 2006), of chronic renal failure (Kattah and Garovic, 2005; McDonald et al., 2003; Williams, 2003) and a specific risk factor of cardio-cerebrovascular mortality (Magnussen et al., 2009). According to Magnusson et al. (2009), the relative long-term risk of developing hypertension is multiplied by 4; the risk of diabetes and metabolic syndrome multiplied by 3; the risk of coronary heart disease and stroke multiplied by 2. Cardiovascular risk is particularly important when pregnancy was complicated by maternal and fetal events or occurring precociously (Williams, 2003; Newstead et al., 2007). Early PE is associated with a relative risk of death by 7 of CV disease. Several pathophysiological factors are common between CV disease and preeclampsia: endothelial dysfunction, hypertension, obesity, insulin resistance, dyslipidemia and CV heredity. Metabolic syndrome could be the link between preeclampsia and CV disease. Hypertension in pregnancy and preeclampsia could unmask metabolic syndrome "latent" existing (Silva et al., 2008). Recently, scientific societies have published guidelines dedicated to cardiovascular risk in women and for the prevention of stroke in women. They recognize hypertension in pregnancy and preeclampsia as specific emerging risk (Mosca et al., 2011; European Society of Gynecology et al., 2011; Bushnell et al., 2014). Paradoxically, information and prevention of these women at risk is insufficient to ignorance and lack of awareness among health professionals (Brown et al., 2013). The education of women has become a major issue of prevention, developing specific consultation after delivery, encouraging them to optimize their lifestyle with a coordinated follow-up (Newstead et al., 2007; Mosca et al., 2011; European Society of Gynecology et al., 2011; Bushnell et al., 2014, Harskamp and Zeeman, 2007). In the end, the implementation of structured care pathway, further monitoring of these women, aims to improve the practices of health professionals (Manten et al., 2007; Adams et al., 2014; Mounier-Vehier et al., 2014).
authors.affiliation: Université de Lille, CHU de Lille, institut cardio-pulmonaire, service de médecine vasculaire et HTA, 59000 Lille, France. Electronic address: clairemouniervehier@orange.fr.
authors.forename: Claire
authors.initials: C
authors.lastname: Mounier-Vehier
authors.affiliation: Université de Lille, CHU de Lille, institut cardio-pulmonaire, service de médecine vasculaire et HTA, 59000 Lille, France.
authors.forename: Anne-Laure
authors.initials: AL
authors.lastname: Madika
authors.affiliation: Université de Lille, CHU de Lille, institut cardio-pulmonaire, service de médecine vasculaire et HTA, 59000 Lille, France.
authors.forename: Fanny
authors.initials: F
authors.lastname: Boudghène-Stambouli
authors.affiliation: Université de Lille, CHU de Lille, institut cardio-pulmonaire, service de médecine vasculaire et HTA, 59000 Lille, France.
authors.forename: Guillaume
authors.initials: G
authors.lastname: Ledieu
authors.affiliation: Université de Lille, CHU de Lille, institut cardio-pulmonaire, service de médecine vasculaire et HTA, 59000 Lille, France.
authors.forename: Pascal
authors.initials: P
authors.lastname: Delsart
authors.affiliation: Assistance publique-Hôpitaux de Paris, université Paris-Descartes, maternité Port- Royal, centre hospitalier universitaire Cochin-Broca Hôtel-Dieu, 123, boulevard Port-Royal, 75014 Paris, France.
authors.forename: Vassilis
authors.initials: V
authors.lastname: Tsatsaris
mesh_terms: D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control; D005260:Female; D006801:Humans; D046110:Hypertension, Pregnancy-Induced / Q000628:therapy; D000068097:Maternal Health; D011247:Pregnancy; D012307:Risk Factors